Financhill
Sell
32

VRCA Quote, Financials, Valuation and Earnings

Last price:
$0.69
Seasonality move :
24.89%
Day range:
$0.62 - $0.71
52-week range:
$0.61 - $11.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.28x
P/B ratio:
196.35x
Volume:
1.5M
Avg. volume:
738.9K
1-year change:
-90.02%
Market cap:
$58.7M
Revenue:
$5.1M
EPS (TTM):
-$1.84

Earnings Data

Next earnings date for VRCA
Feb 28
2025
Most recent earnings per share
-$0.49
Missed by $0.10
(Nov 4/2024)
Consensus Estimate
-$0.39
(Nov 4/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VRCA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $710.3K -- -- -$0.28 --
11/04/2024 Q3 $5.3M -$1.8M -$0.49 -$0.39 -$0.10
08/14/2024 Q2 $4.5M $5.2M -$0.37 -$0.40 $0.03
05/13/2024 Q1 $2.7M $3.8M -$0.44 -$0.44 --
02/29/2024 Q4 $948K $2M -$0.54 -$0.56 $0.02
11/09/2023 Q3 -- -- -$0.54 -$0.39 -$0.15
08/08/2023 Q2 -- -- -$0.24 -$0.20 -$0.04
05/09/2023 Q1 -- -- -$0.15 -$0.17 $0.02
03/06/2023 Q4 -- -- -$0.14 -$0.19 $0.05
11/07/2022 Q3 -- -- $0.00 -$0.10 $0.10
08/11/2022 Q2 -- -- -$0.37 -$0.32 -$0.05
05/09/2022 Q1 -- -- -$0.31 -$0.45 $0.14
03/02/2022 Q4 -- -- -$0.35 -$0.48 $0.13
11/12/2021 Q3 -- -- -$0.47 -$0.51 $0.04
08/10/2021 Q2 -- -- -$0.43 -$0.41 -$0.02
05/07/2021 Q1 -- -- -$0.04 -$0.34 $0.30
03/04/2021 Q4 -- -- -$0.52 -$0.41 -$0.11
11/09/2020 Q3 -- -- -$0.42 -$0.43 $0.01
08/05/2020 Q2 -- -- -$0.38 -$0.44 $0.06
05/07/2020 Q1 -- -- -$0.39 -$0.36 -$0.04
03/13/2020 Q4 -- -- -$0.31 -- --
11/06/2019 Q3 -- -- -$0.24 -- --
08/07/2019 Q2 -- -- -- -- --
05/07/2019 Q1 -- -- -- -- --
03/07/2019 Q4 -- -- -$0.30 -$0.26 -$0.04
11/07/2018 Q3 -- -- -$0.27 -$0.25 -$0.02
08/07/2018 Q2 -- -- -$0.51 -$0.36 -$0.15

Verrica Pharmaceuticals Earnings Questions

  • How Much did Verrica Pharmaceuticals Generate in Revenue Last Quarter?

    Verrica Pharmaceuticals reported -$1.8M worth of top line sales in its most recent quarter.

  • Did Verrica Pharmaceuticals Beat Earnings Last Quarter?

    Verrica Pharmaceuticals announced earnings per share of -$0.49 which represents a miss of analyst forecast a -$0.39 per share.

  • Is Verrica Pharmaceuticals Profitable?

    Verrica Pharmaceuticals reported -$2.2M that represents -$0.05 per share over the last quarter.

  • What is the Analyst Consensus for Verrica Pharmaceuticals EPS Next Year?

    Verrica Pharmaceuticals's earnings are forecast to decrease from -$1.48 per share to -$1.45 per share next year representing a decrease of -1.08%.

  • When is Verrica Pharmaceuticals's Earnings Date?

    Verrica Pharmaceuticals's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is down 3.22% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 4.72% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is down 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock